Josef Von-Rickenbach, Director at Rein Therapeutics, holds 62.51K shares in Rein Therapeutics (Ticker: RNTX), holds 125.00K shares in Virgin Orbit Holdings (Ticker: VORBQ), holds 521.13K shares in Parexel (Ticker: PRXL). Most recently, Josef Von-Rickenbach Bought ― shares of Rein Therapeutics on May 28, 2026 for an estimated value of $49.31K.
What is the percentage of profitable transactions made by Josef Von-Rickenbach?
The percentage of profitable transactions made by Josef Von-Rickenbach is 63%.
What is the average return per transaction made by Josef Von-Rickenbach?
The average return per transaction made by Josef Von-Rickenbach is 17.90%.
What stocks does Josef Von-Rickenbach hold?
Josef Von-Rickenbach holds: RNTX, VORBQ, PRXL stocks.
What was Josef Von-Rickenbach’s latest transaction?
Josef Von-Rickenbach latest transaction was an Informative Buy of $49.31K.
What was Josef Von-Rickenbach's most profitable transaction?
Josef Von-Rickenbach’s most profitable transaction was an Informative Buy of RNTX stock on September 3, 2019. The return on the trade was 65.40%.
What is Josef Von-Rickenbach's role in Rein Therapeutics?
Josef Von-Rickenbach's role in Rein Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.